Cite

    B. Elewski et al.. “A phase II, randomized, double‐blind, placebo‐controlled, dose‐ranging study to evaluate the efficacy and safety of VT‐1161 oral tablets in the treatment of patients with distal and lateral subungual onychomycosis of the toenail.” British journal of dermatology, vol. 184, 2021, pp. 270–280. http://access.bl.uk/ark:/81055/vdc_100122179559.0x000060